VSMD (Vasamed) YoY EBITDA Growth: 24.26% (As of Sep. 2006)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Vasamed YoY EBITDA Growth?

Vasamed VSMD YoY EBITDA Growth is 24.26% as of Sep. 2006.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Vasamed's YoY EBITDA Growth for the quarter that ended in Sep. 2006 was 24.26%.

Vasamed's EBITDA per Share for the three months ended in Sep. 2006 was $-0.31.

Vasamed YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Vasamed's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vasamed YoY EBITDA Growth Chart

Vasamed Annual Data
Trend Dec96 Dec97 Dec98 Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.09 45.63 -10.29 -154.96 29.67

Vasamed Quarterly Data
Dec01 Mar02 Jun02 Sep02 Dec02 Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.54 1.70 -19.37 6.65 24.26

Vasamed YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Vasamed's YoY EBITDA Growth for the fiscal year that ended in Dec. 2005 is calculated as:

YoY EBITDA Growth (A: Dec. 2005 )
=(EBITDA per Share (A: Dec. 2005 )-EBITDA per Share (A: Dec. 2004 ))/ | EBITDA per Share (A: Dec. 2004 ) |
=(-1.23--1.749)/ | -1.749 |
=29.67 %

Vasamed's YoY EBITDA Growth for the quarter that ended in Sep. 2006 is calculated as:

YoY EBITDA Growth (Q: Sep. 2006 )
=(EBITDA per Share (Q: Sep. 2006 )-EBITDA per Share (Q: Sep. 2005 )) / | EBITDA per Share (Q: Sep. 2005 )) |
=(-0.306--0.404)/ | -0.404 |
=24.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 24.26% mean?
Vasamed (VSMD) has a YoY EBITDA Growth of 24.26% as of Sep. 2006. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Vasamed and its competitors.
Is Vasamed's YoY EBITDA Growth too high?
Vasamed's current YoY EBITDA Growth is 24.26%.
How does Vasamed's YoY EBITDA Growth compare to LENSF and WHSI?
Vasamed's YoY EBITDA Growth of 24.26% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Medical Devices & Instruments company?
A good YoY EBITDA Growth depends on the Medical Devices & Instruments industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Vasamed and its competitors. Vasamed's current YoY EBITDA Growth is 24.26%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vasamed stock overvalued right now?
Vasamed (VSMD) has a current YoY EBITDA Growth of 24.26%. The current YoY EBITDA Growth is 24.26%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Vasamed (VSMD), the current YoY EBITDA Growth is 24.26% as of Sep. 2006. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vasamed Business Description

Address 7615 Golden Triangle Drive, Suite A, Eden Prairie, MN, USA, 55344-3733
Vasamed Inc develops, manufactures and markets low-cost, non-invasive peripheral and cardiovascular diagnostic systems for hemodynamic assessment.